Austin, Texas, United States, June 9th, 2025, FinanceWire
- The company’s non-invasive fingerprint drug screening system uses sweat from the fingerprint to screen for drugs such as cannabis, cocaine, methamphetamine and opiates.
- Results come back in under ten minutes, which supports faster on-site decisions in treatment and justice settings.
- INBS is seeking FDA approval and wider entry into the U.S. market, where it currently operates in a Forensic Use Only capacity.
- The company has over 450 active accounts in 24 countries and targets sectors such as healthcare, justice and workplace safety.
- INBS has partnered with SMARTOX, a U.S. distributor, to reach stakeholders in criminal justice and addiction recovery.
Intelligent Bio Solutions (NASDAQ: INBS), a medical technology company that specializes in rapid, non-invasive testing solutions, recently went to the RISE25 conference to demonstrate its portable Intelligent Fingerprint Drug Screening System, as part of its continuing push into the U.S. market for rapid, non-invasive screening technologies (https://ibn.fm/1JSTS).
The event, held in Florida from May 28 to 31, drew over 7,000 professionals from addiction treatment, mental health and criminal justice. The conference has become a national gathering point for…
NOTE TO INVESTORS: IBN is a multifaceted financial news, content creation and publishing company used by public and private companies alike to build investor awareness and recognition. More information can be found at https://www.InvestorBrandNetwork.com
The full terms of use and disclaimers that apply to all content provided by IBN, wherever it is published or re-published, are set out on the InvestorBrandNetwork website: http://IBN.fm/Disclaimer
The latest news and updates relating to INBS can be found in the company’s newsroom at https://ibn.fm/INBS
Corporate Communications
IBN
Austin, Texas
www.InvestorBrandNetwork.com
512.354.7000 Office
Editor@InvestorBrandNetwork.com
Contact
IBN
www.InvestorBrandNetwork.com
Editor@InvestorBrandNetwork.com
